Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Inherited Metabolic Disease|November 3, 2020
Developing new treatments in partnership for primary mitochondrial disease: What does industry need from academics, and what do academics need from industry?Paul W ThompsonDrug Discovery Today|January 13, 2009
Monitoring the amyloid beta-peptide in vivo--caveat emptorPaul W Thompson, Andrew LockhartInjury|April 15, 2004
The annual incidence and seasonal variation of fractures of the distal radius in men and women over 25 years in Dorset, UKPaul W Thompson, Julia Taylor, Adrian DawsonJournal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Intercellular adhesion molecule (ICAM)-1, but not ICAM-2, activates RhoA and stimulates c-fos and rhoA transcription in endothelial cellsPaul W Thompson, Anna M Randi, Anne J RidleyCytokine|September 8, 2007
Interleukin-10 is upregulated by nanomolar rosiglitazone treatment of mature dendritic cells and human CD4+ T cellsPaul W Thompson, Andrew I Bayliffe, Andrew P Warren, et al.Nature Reviews. Drug Discovery|January 14, 2025
Targeting mitophagy in neurodegenerative diseasesOdetta Antico, Paul W Thompson, Nicholas T Hertz, et al.Diabetes|November 25, 2005
Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetesHassan Rahmoune, Paul W Thompson, Joanna M Ward, et al.Transplantation|June 26, 2007
Rosiglitazone suppresses cyclosporin-induced chronic transplant dysfunction and prolongs survival of rat cardiac allograftsYan Chen, Yan Liu, Zhengwei Yuan, et al.Journal of Neurochemistry|February 20, 2009
Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologiesPaul W Thompson, Liang Ye, Jennifer L Morgenstern, et al.Biomaterials|December 21, 2006
Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitroKarin Müller, Jeremy N Skepper, Mihaly Posfai, et al.Pageof 2